Quick Answer
BioAtla, Inc. reported Research And Development Expense of $43.57 million for the year ending 2025.
- BioAtla, Inc. showed a decrease of -30.9% in Research And Development Expense from 2024 to 2025.
- This data is from BioAtla, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), BioAtla, Inc.'s Research And Development Expense has grown by 68.1%.
- Historical annual values: Fiscal year 2025: $43.57 million | Fiscal year 2024: $63.10 million | Fiscal year 2023: $103.73 million | Fiscal year 2022: $79.35 million | Fiscal year 2021: $58.27 million | Fiscal year 2020: $19.93 million | Fiscal year 2019: $25.92 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: